The question, "Is Impossible meat FDA approved?" is a common one among consumers concerned about novel food ingredients. The regulatory process for ingredients like Impossible's soy leghemoglobin does not follow a standard pre-market 'approval' model like pharmaceuticals. Instead, it operates under the 'Generally Recognized as Safe' (GRAS) pathway. Through this process, Impossible Foods has successfully demonstrated the safety of its key ingredient to the FDA.
The GRAS Pathway for Soy Leghemoglobin
Impossible Foods first pursued the GRAS determination for soy leghemoglobin in 2014, with a panel of experts affirming its safety. However, the initial notification was withdrawn after the FDA requested more data. Impossible Foods responded by submitting a new notification in 2017 with additional testing results, including animal studies.
The 'No Questions' Letter
In July 2018, the FDA issued a "no questions" letter for the GRAS notification, indicating that based on the provided information, the agency did not question the company's conclusion that soy leghemoglobin is safe for its intended use. This letter acknowledges the company's safety assessment but is not a formal FDA approval.
Color Additive Approval for Raw Product
Selling the raw Impossible patty required an additional step due to federal regulations concerning ingredients that impart color to food. Since soy leghemoglobin provides the product's red color, it needed to be approved as a color additive.
In July 2019, the FDA approved soy leghemoglobin as a color additive, enabling the retail sale of uncooked Impossible products. This separate approval further confirmed the ingredient's safety.
The FDA and Legal Challenges
Legal challenges have been brought against the FDA regarding its review of heme. However, in May 2021, a federal appeals court upheld the FDA's decision, stating that the agency had substantial evidence to support its safety finding. This legal outcome reinforces the FDA's rigorous process.
Comparison: FDA vs. Other Regulatory Bodies
Various international regulatory bodies have also reviewed the safety of Impossible Foods' ingredients. The European Union's review process differs from the FDA's GRAS pathway and color additive approval, and as of late 2023, it had not yet granted authorization for soy leghemoglobin. For a detailed comparison of regulatory bodies, {Link: see the Impossible Foods blog https://impossiblefoods.com/blog/setting-the-record-straight-regarding-the-center-for-food-safety-impossible-foods-long-standing-track-record-of-safety-and-transparency}.
Conclusion
While there isn't a single "FDA approval" document in the traditional sense, Impossible Foods has successfully navigated the US regulatory process through the GRAS notification for soy leghemoglobin. The FDA issued a "no questions" letter for GRAS and approved it as a color additive, allowing retail sales. Safety testing, favorable legal outcomes, and international regulatory confirmations support the safety of Impossible meat. For further details on the FDA's regulatory framework for food ingredients, you can visit the official FDA website.